Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience

Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience

Adverse drug reactions (ADRs) are major concerns to the public health. To monitor ADRs and ensure patients' safety, the Pharmacovigilance Programme of India (PvPI) has been established by the Government of India in 2010. The programme is intact with the Public-Private Partnership (3Ps) in pharm...

Full description

Bibliographic Details
Main Authors: Vivekanandan Kalaiselvan, Shatrunajay Shukla, Shubhang Arora, Tarani Prakash Shrivastava, Rajeev Singh Raghuvanshi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Public Health
Subjects:
pharmacovigilance
public-private partnership
Individual Case Safety Reports (ICSRs)
drug safety
Adverse drug reactions (ADRs)
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.930696/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.930696/full

Similar Items